MicroRNA-421 Dysregulation is Associated with Tetralogy of Fallot

Douglas C Bittel1, Nataliya Kibiryeva2, Jennifer A Marshall3

  • 1Ward Family Heart Center, Children's Mercy Hospitals and Clinics and University of Missouri-Kansas City School of Medicine, 2401 Gillham Rd. Kansas City, MO 64108, USA. dbittel@cmh.edu.

Cells
|September 27, 2014
PubMed

Insights

MicroRNAs are crucial for heart development. In tetralogy of Fallot (TOF), miR-421 is upregulated and inversely correlated with SOX4, suggesting its role in this congenital heart defect.

Area of Science:

  • Cardiovascular Biology
  • Developmental Biology
  • Molecular Genetics

Background:

  • MicroRNAs (miRNAs) are vital for vertebrate heart development and implicated in congenital heart defects.
  • Idiopathic tetralogy of Fallot (TOF) involves complex genetic and developmental abnormalities.
  • Previous studies identified altered miRNA expression in TOF myocardium.

Purpose of the Study:

  • To investigate the role of specific microRNAs, particularly miR-421, in the pathogenesis of tetralogy of Fallot.
  • To explore the relationship between dysregulated miRNAs and key cardiac developmental genes in TOF.
  • To examine the functional impact of miR-421 on cardiac cells relevant to TOF.

Main Methods:

  • Expression profiling of 61 significantly altered microRNAs in right ventricular (RV) myocardium from infants with TOF versus controls.
  • Correlation analysis between differentially expressed miRNAs and 44 known cardiac development genes.
  • Functional studies involving knockdown and overexpression of miR-421 in primary RV cells from TOF and control infants.

Main Results:

  • 61 microRNAs showed altered expression in TOF myocardium compared to controls.
  • Predicted targets of dysregulated miRNAs were enriched in cardiac development gene networks.
  • miR-421 was significantly upregulated in TOF RV tissue and inversely correlated with SOX4 expression.

Conclusions:

  • Dysregulation of miR-421 is associated with tetralogy of Fallot.
  • miR-421's interaction with SOX4, a Notch pathway regulator, suggests a potential mechanism in TOF pathogenesis.
  • Further investigation of miR-421 is warranted for understanding and potentially treating TOF.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.8K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
591
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
920